Practice observed

Darnborough, Sally
September 2012
Menopause International;Sep2012, Vol. 18 Issue 3, p116
Academic Journal
Case Study
The article presents a case study of a 74 year old woman who has undergone the estrogen replacement therapy (ERT) and was suffering from vaginal bleeding. Her case was investigated and was expected to have a vasovagal episode. She was advised to stop her ERT and commence antiplatelet therapy (clopidogrel) and statin for preventive purpose. She reported an awful feeling and started self-medicating with Gingko biloba which stopped her bleeding and provided a remedy for menopausal symptoms.


Related Articles

  • Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel.  // Current Medical Literature: Lysosomal Storage Disease;2012, Vol. 10 Issue 1, p115 

    The article discusses aspects of the study by O. Smith and colleagues on the gastrointestinal (GI) bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel. The authors say that the GI bleeding complications is the downside of cardiovascular protective combination of...

  • Clopidogrel in Secondary Ischemic Stroke Prevention. Belv�s, Robert; Pagonabarraga, Javier; Santamar�a, Amparo; Kulisevsky, Jaime // Recent Patents on Cardiovascular Drug Discovery;Jun2008, Vol. 3 Issue 2, p119 

    The results obtained in the CAPRIE study in 1996 led to the introduction of the clopidogrel as a new antiplatelet drug in the secondary prevention of acute myocardial infarct (AMI), ischemic stroke (IS) and symptomatic peripheral artery disease (PAD). Clopidogrel showed a similar efficacy and...

  • PANEL DISCUSSION.  // Drugs;2010 Supplement 1, Vol. 70, p15 

    No abstract available.

  • Clopidogrel, Warfarin, and Statins: Pharmacogenetics Versus Laboratory Monitoring - What You Need to Know. Vinall, Maria // MD Conference Express;Jan2011, p8 

    The article discusses the pharmacogenetics of clopidogrel, warfarin, and statins. A balance between thrombotic and bleeding events is deemed critical to achieve the optimal outcomes of using antiplatelet therapy in preventing atherothrombotic events in coronary artery disease. Favorable trends...

  • Prolonged Clopidogrel Use After Cardiac Stenting Is Not Beneficial. CRAWFORD.-FAUCHER, AMY // American Family Physician;11/1/2012, Vol. 86 Issue 9, p853 

    This article discusses research on outcomes with six and 24 months of dual-antiplatelet therapy in patients receiving dual-eluting or bare-metal stents. Investigators discovered a twofold increase in bleeding complications requiring medical or surgical treatment or transfusion in the 24-month...

  • Perioperative Clopidogrel Is Seven Days Enough? GRUJIC, DEJAN; MARTIN, DAVID // American Surgeon;Oct2009, Vol. 75 Issue 10, p909 

    Despite the prevalence of surgical candidates on clopidogrel, no definitive guidelines exist for stopping the drug preoperatively. A 7 day off-clopidogrel period is commonly considered safe with regards to bleeding complications. We sought to put the 7-day window to the test with regards to...

  • Hemothorax after chest tube insertion for pneumothorax as a complication of clopidogrel. Ohara, Gen; Kagohashi, Katsunori; Kurishima, Koichi; Miyazaki, Kunihiko; Satoh, Hiroaki // Central European Journal of Medicine;Aug2013, Vol. 8 Issue 4, p406 

    Hemorrhagic complications are recognized when anti-platelet agents are used during or after surgical procedures. We present a 69-year-old male patient who developed hemothorax after chest tube insertion for pneumothorax as a complication of clopidogrel and aspirin following ischemic heart...

  • clopidogrel.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p469 

    A definition of the medical term "clopidogrel," which refers to a platelet aggregation inhibitor intended for reducing atherosclerotic events, is presented.

  • Increased bleeding, mortality with >1 year of DAPT post-stenting.  // Reactions Weekly;Apr2015, Vol. 1546 Issue 1, p8 

    The article reports on the findings of a research by Italian-based researchers who performed a meta-analysis of randomised controlled trials comparing different dual antiplatelet therapy (DAPT) and found it was associated with increased major bleeding and mortality .


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics